Daito Pharmaceutical Co., Ltd. (Daito) Daito Pharmaceutical Co., Ltd. (Daito)

Font Size

  • Standard
  • Expansion
  • JPNJPN
  • ENGENG
  • CHN(Simplified)CHN

Contact Us

  • Company Profile
    • Company information top
    • Top Message
    • Company Profile
    • Business Overview
    • Access
    • Company Creed and Management Philosophy
    • Policies
    • Organization Chart and Executives
    • Corporate History
    • Group Companies
  • Businesses
    • Business Content Top
    • APIs
    • Generic Drug
      Development and Manufacture
    • Contract Manufacture of Ethical Drugs
    • OTC drugs
    • Health Care
    • Overseas Business
    • Quality Assurance
    • Online Company Tour
  • Investor Relations
    • For shareholders and investors
    • IR News
    • Management Information
    • Financial Highlights
    • QUICK&NOMURA
      Company Report
    • Integrated Reports
    • Corporate Governance Report
    • IR Library
    • Stocks
    • IR Calendar
    • FAQ
    • Electronic Public Notice
    • Disclosure Policy
    • Disclaimer
  • Sustainability
    • Sustainability Top
    • Integrated Reports
    • CSR-related Activities
    • Process of Identifying Material CSR Issues
    • CSR Policy
    • Code of Conduct for Sustainability / Sustainable Sourcing Guidelines
    • Policy of Respect for Human Rights
    • Anti-Corruption (Bribery) Policy and Guideline
    • CSR Reports
    • Employment Information
    • Message from the Director of Human Resources and General Affairs
    • Daito's work
    • The Person We Want
    • About Our Jobs
    • New Graduates Recruitment
    • Mid-Career Recruitment
  • Contact Us

Keyword Search

Integrated Reports <!-- -->

Integrated Reports

  • Top
  • Investor Relations
  • IR Library
  • Integrated Reports
  • IR News
  • Management Information
  • Financial Highlights
  • QUICK&NOMURA Company Report
  • Integrated Reports
  • Corporate Governance Report
  • IR Library
  • Stocks
  • IR Calendar
  • FAQ
  • Electronic Public Notice
  • Disclosure Policy
  • Disclaimer
  • Financial Results
  • Securities Reports
  • Shareholder Newsletter
  • Financial Results Supplementary Explanation / Presentation Materials
  • Integrated Reports
  • Other IR Materials (English Documents Available Here)

Integrated Report/CSR Report

[Available in Japanese Only]
For Shareholders and Investors
IR Information
  • IR News
  • Management Information
  • Financial Highlights
  • Integrated Reports
  • Corporate Governance Report
  • IR Library
  • Stocks
  • IR Calendar
  • FAQ
  • Electronic Public Notice
  • Disclosure Policy
  • Disclaimer
Daito Pharmaceutical Co., Ltd. (Daito)

326 Yokamachi, Toyama City, Toyama Prefecture 939-8567
TEL: 076 (421) 5665

  • Company Profile

    • Top Message
    • Company Profile
    • Business Overview
    • Access
    • Company Creed and Management Philosophy
    • Policies
    • Organization Chart and Executives
    • Corporate History
    • Group Companies
  • Businesses

    • APIs
    • Generic Drug
      Development and Manufacture
    • Contract Manufacture of Ethical Drugs
    • OTC drugs
    • Overseas Business
    • Quality Assurance
    • Online Company Tour
  • Investor Relations

    • Management Information
    • Financial Highlights
    • QUICK&NOMURA
      Company Report
    • Integrated Reports
    • Corporate Governance Report
    • IR Library
    • Stocks
    • IR Calendar
    • FAQ
    • Electronic Public Notice
    • Disclosure Policy
    • Disclaimer
  • Sustainability

    • Integrated Reports
    • CSR-related Activities
    • Process of Identifying Material CSR Issues
    • CSR Policy
    • Code of Conduct for Sustainability / Sustainable Sourcing Guidelines
    • Policy of Respect for Human Rights
    • Anti-Corruption (Bribery) Policy and Guideline
    • CSR Reports
  • Contact Us

© 2022 Daito Pharmaceutical Co., Ltd. All Rights Reserved.

  • Notes on Use
  • Policy for Observing Laws and Regulations on Personal Information Protection